Device Closure of Patent Foramen Ovale in Patients With Cryptogenic Stroke: The Tide Has Turned

Affiliations

¹ Division of Cardiology, Department of Medicine, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York. Electronic address: dnf9001@med.cornell.edu.
² Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York.
³ Division of Cardiology, Department of Medicine, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts; Baim Institute for Clinical Research, Boston, Massachusetts.

Free article

Editorial

Dmitriy N Feldman et al. J Am Coll Cardiol. 2018.

Free article

. 2018 May 22;71(20):2343-2345.

doi: 10.1016/j.jacc.2018.03.460.

¹ Division of Cardiology, Department of Medicine, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York. Electronic address: dnf9001@med.cornell.edu.
² Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York.
³ Division of Cardiology, Department of Medicine, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts; Baim Institute for Clinical Research, Boston, Massachusetts.

No abstract available

Keywords: patent foramen ovale; stroke; transcatheter PFO closure.

Comment on

Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial.
Lee PH, Song JK, Kim JS, Heo R, Lee S, Kim DH, Song JM, Kang DH, Kwon SU, Kang DW, Lee D, Kwon HS, Yun SC, Sun BJ, Park JH, Lee JH, Jeong HS, Song HJ, Kim J, Park SJ. Lee PH, et al. J Am Coll Cardiol. 2018 May 22;71(20):2335-2342. doi: 10.1016/j.jacc.2018.02.046. Epub 2018 Mar 12. J Am Coll Cardiol. 2018. PMID: 29544871 Clinical Trial.